Britain approves Pfizer/BioNTech's updated COVID-19 booster vaccine

FILE PHOTO: Vaccination Clinic at Belfast Central Fire Station in Northern Ireland

(Reuters) - Britain's medicines regulator on Saturday approved Pfizer/BioNTech's updated bivalent COVID-19 booster shot for people aged 12 years and older.

The Medicines and Healthcare products Regulatory Agency said the decision was based on data from a clinical trial that showed a booster dose with the bivalent Pfizer/BioNTech vaccine triggers a strong immune response against both the Omicron and the original strain.

(Reporting by Shivam Patel in Bengaluru; Editing by Mike Harrison)